IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson's disease and other neurological conditions

被引：0
|
作者：
Jost, W.
Pagan, F.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1016
引用
收藏
页码：S453 / S454
页数：2
相关论文
共 50 条
  • [1] Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson's disease and other neurologic conditions
    Pagan, F.
    Jost, W.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    MOVEMENT DISORDERS, 2018, 33 : S754 - S754
  • [2] ATTAINMENT OF PHYSIOLOGIC SALIVARY FLOW RATE WITH LONGTERM INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA IN PARKINSON'S DISEASE AND OTHER NEUROLOGIC CONDITIONS
    Pagan, F.
    Jost, W. H.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E85 - E85
  • [3] ATTAINMENT OF PHYSIOLOGIC SALIVARY FLOW RATE WITH LONGTERM INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA IN PARKINSON'S DISEASE AND OTHER NEUROLOGIC CONDITIONS
    Jost, W.
    Pagan, F.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 39 - 40
  • [4] MYSTICOL: A controlled study of Myobloc in the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions
    Hubble, J.
    Isaacson, S.
    Severt, L.
    Clinch, T.
    MOVEMENT DISORDERS, 2016, 31 (09) : E3 - E3
  • [5] SIAXI: INCOBOTULINUMTOXINA FOR SIALORRHEA IN PARKINSON'S DISEASE, STROKE, AND OTHER ETIOLOGIES-PHASE 3 RESULTS
    Jost, Wolfgang
    Friedman, Andrzej
    Michel, Olaf
    Flatau-Baque, Birgit
    Hast, Michael
    Csikos, Janos
    Blitzer, Andrew
    MUSCLE & NERVE, 2018, 58 : S57 - S57
  • [6] SIAXI: IncobotulinumtoxinA for sialorrhea in Parkinson's disease, stroke, and other etiologies-Phase 3 Results
    Blitzer, Andrew
    Friedman, Andrzej
    Michel, Olaf
    Flatau-Baque, Birgit
    Csikos, Janos
    Jost, Wolfgang
    NEUROLOGY, 2018, 90
  • [7] SIAXI: Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: results of a Phase III, placebo-controlled, randomised, doubleblind study
    Csikos, J.
    Blitzer, A.
    Friedman, A.
    Michel, O.
    Flatau-Baque, B.
    Jost, W.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 12 - 12
  • [8] LONG-TERM EFFICACY OF INCOBOTULINUMTOXINA IN THE MANAGEMENT OF SIALORRHEA IN PARKINSON'S DISEASE
    Ianieri, Giancarlo
    Marvulli, Riccardo
    Gallo, Giulia
    TOXICON, 2018, 156 : S45 - S46
  • [9] INCOBOTULINUMTOXINA TO TREAT SIALORRHEA IN PARKINSON'S DISEASE: A REAL-LIFE STUDY
    Bergmans, B.
    Schotte, V.
    Sys, N.
    Van Massenhove, E.
    Van Zandijcke, M.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E69 - E70
  • [10] IncobotulinumtoxinA to treat sialorrhea in Parkinson's disease: a real-life study
    Bergmans, B.
    Winter, N.
    Schotte, V.
    Sys, N.
    Van Massenhove, E.
    Couckuyt, H.
    Van Zandijcke, M.
    MOVEMENT DISORDERS, 2022, 37 : S319 - S320
12345